Endocannabinoids are potential inhibitors of glioblastoma multiforme proliferation-Reference-Cited by-同舟云学术

Endocannabinoids are potential inhibitors of glioblastoma multiforme proliferation

Published:2023-03 Issue:2 Volume:21 Page:120-129
ISSN:2095-4964
Container-title:Journal of Integrative Medicine
language:en
Short-container-title:Journal of Integrative Medicine

Author:

Duzan Ashraf,Reinken Desiree,McGomery Timothy L.,Ferencz Nicholas M.,Plummer Jacob M.,Basti Mufeed M.

Publisher

Elsevier BV

Subject

Complementary and alternative medicine

Reference112 articles.

1. Institute for Health Metrics and Evaluation. Total cancers—cause. (2019) [2020-11-03]. https://www.healthdata.org/results/gbd_summaries/2019/total-cancers-level-2-cause.

2. CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2009–2013;Ostrom;Neuro Oncol,2016

3. The leading causes of death in the US for 2020;Ahmad;JAMA,2021

4. Aging, cellular senescence, and cancer;Campisi;Annu Rev Physiol,2013

5. Ligand-dependent activation of the hedgehog pathway in glioma progenitor cells;Ehtesham;Oncogene,2007

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CENPA facilitates glioma stem cell stemness and suppress ferroptosis to accelerate glioblastoma multiforme progression by promoting GBP2 transcription;Pathology - Research and Practice;2024-08

2. Soloxolone para-methylanilide effectively suppresses aggressive phenotype of glioblastoma cells including TGF-β1-induced glial-mesenchymal transition in vitro and inhibits growth of U87 glioblastoma xenografts in mice;Frontiers in Pharmacology;2024-07-29

3. Neuroinflammation in Glioblastoma: The Role of the Microenvironment in Tumour Progression;Current Cancer Drug Targets;2024-06

4. The application of cannabidiol in the treatment of glioblastoma;Acta Poloniae Pharmaceutica - Drug Research;2023-06-29

5. FBLIM1 mRNA is a novel prognostic biomarker and is associated with immune infiltrates in glioma;Open Medicine;2023-01-01